Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-24 @ 11:58 PM
NCT ID:
NCT01025258
Eligibility Criteria:
Inclusion Criteria:
1. Patients with diagnosis of Cystic fibrosis at all ages.
2. CF patients that should be treated with one or more of these chronic medications: Tobi (Tobramycin), Coliracin (Colistin), Pulmozyme (Dornase Alpha), Hypertonic Saline (HS), Creon (pancreatic enzymes), AquaADEKs (Multivitamin).
3. Patients willing to participate in a trial.
4. Presence of a parent/guardian capable of providing informed consent.
5. Patients attending CF clinic at least once every 12 months.
Exclusion Criteria:
1. Absence of a parent/guardian or unwillingness to provide permission.
2. Potential participant declines to provide assent.
3. Transplant patients.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
60 Years
Study:
NCT01025258
Study Brief:
Protocol Section:
NCT01025258